Medicine and Dentistry
Prostate Cancer
100%
Systematic Review
53%
Quality of Life
37%
Randomized Controlled Trial
27%
Malignant Neoplasm
26%
Patient-Reported Outcome
24%
Urology
22%
Health Care
20%
Lithotripsy
18%
Cancer Therapy
17%
Clinical Trial
17%
Clear Cell Renal Cell Carcinoma
14%
Ureteroscopy
13%
Extracorporeal Shock Wave Lithotripsy
13%
COVID-19
13%
Ureter
13%
Surgery
13%
Disease
12%
Cancer Research
12%
Bladder Cancer
12%
Survivorship in Cancer Care
12%
Cancer Treatment
12%
Brief Pain Inventory
11%
Health Care Cost
11%
Kidney Cancer
10%
Clinician
10%
Catheter Care
9%
Functional Assessment
9%
Cost-Effectiveness Analysis
8%
Cancer Diagnosis
8%
Radical Nephrectomy
7%
Self Esteem
7%
Awareness
7%
Partial Nephrectomy
7%
Prevalence
7%
Supportive Care
7%
Quality Adjusted Life Year
7%
Diagnosis
7%
Short Form 36
6%
Inappropriate Prescribing
6%
Case Presentation
6%
Patient Participation
6%
General Practitioner
6%
Noninferiority Trial
6%
Stakeholder Engagement
6%
Antiphospholipid Syndrome
6%
Psycho-Oncology
6%
Prognostic Factor
6%
Radiation Therapy
6%
Androgen Deprivation Therapy
6%
Nursing and Health Professions
Prostate Cancer
45%
Systematic Review
38%
Malignant Neoplasm
36%
Catheter
29%
Health Care Personnel
27%
Patient-Reported Outcome
18%
Cancer Therapy
17%
Quality of Life
14%
Cost Effectiveness Analysis
14%
Disease
13%
Urinary Tract Cancer
12%
Breast Cancer
12%
Penis Cancer
12%
Lithotripsy
12%
Cancer Screening
12%
Brief Pain Inventory
11%
Prevalence
9%
Functional Assessment
9%
Catheterization
7%
Distress Syndrome
7%
Chronic Disease
7%
Patient Participation
7%
General Practitioner
6%
Urinary Tract Infection
6%
Cost Utility Analysis
6%
Quality Adjusted Life Year
6%
Mental Health
6%
Kidney Cancer
6%
Teaching Hospital
6%
Patient-Centered Care
6%
Health Policy
6%
Decision Support System
6%
Renal Cell Carcinoma
6%
Self-Efficacy
6%
Hot Flush
6%
Surgery
6%
In Vitro Fertilisation
6%
Clinical Effectiveness
6%
Cigarette Filter
6%
Uterine Cervix Cancer
6%
Secondary Health Care
6%
Marital Status
6%
Indwelling Urinary Catheter
6%
Cancer Registry
6%
Health Program
6%
Information System
6%
Mitomycin
6%
N [bis(1 Aziridinyl)phosphinyl] 4 Iodobenzamide
6%
Practice Guideline
6%
Embryo Transfer
6%
Keyphrases
Prostate Cancer
33%
Patient Participation
18%
Shock Wave Lithotripsy
18%
Surgical Management
18%
Core Outcome Set
15%
Living with
14%
Penile Cancer
13%
Stone Treatment
12%
Ureteroscopic Treatment
12%
Ureteroscopic
12%
Clinical Efficacy
12%
Decision Support Tool
12%
Sector Studies
12%
Healthcare Professionals
12%
Big Data
12%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
10%
European Association of Urology
9%
Randomized Controlled Trial
9%
Guideline Development
8%
Ureteral Stone
8%
Quality-adjusted Life Years
8%
Modified Delphi Method
8%
Localized Prostate Cancer
7%
Patient Preference
7%
Cost-effectiveness
7%
Non-inferiority
7%
Clinical Trials
7%
Supportive Care
6%
Ureter
6%
Patient Values
6%
Prostate Cancer Patients
6%
Stakeholder Perceptions
6%
Hughes Syndrome
6%
EAU Guidelines
6%
Localized Renal Cell Carcinoma
6%
Non-surgical Treatment
6%
Hong Kong Schools
6%
Patient-reported Experience
6%
Good Care
6%
Cancer Research
6%
Literature Synthesis
6%
Cancer Information
6%
Knowledge Landscape
6%
Longitudinal Aging Study in India
6%
Adult Cancer Survivors
6%
Guideline-based
6%
Partial Nephrectomy
6%
Chinese Education
6%
Sustainable Workplace
6%
Transformational Leadership Style
6%